Yüklüyor......
Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
The cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout remains equivocal. Febuxostat had a better safety outcome compared with allopurinol. In this systematic review and meta‐analysis, we searched MEDLINE and Embase for articles published between March 1, 2000 and...
Kaydedildi:
| Yayımlandı: | Clin Cardiol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley Periodicals, Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8259158/ https://ncbi.nlm.nih.gov/pubmed/34013998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23643 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|